Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial

[1]  R. Peto,et al.  Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast. , 2010, Journal of the National Cancer Institute. Monographs.

[2]  J. Cuzick,et al.  A new pathological system for grading DCIS with improved prediction of local recurrence: results from the UKCCCR/ANZ DCIS trial , 2010, British Journal of Cancer.

[3]  D. Farley,et al.  Recent advances and current controversies in the management of DCIS of the breast. , 2008, Cancer treatment reviews.

[4]  Kefah Mokbel,et al.  Current management of DCIS: a review , 2008, Breast Cancer Research and Treatment.

[5]  L. Holmberg,et al.  Absolute risk reductions for local recurrence after postoperative radiotherapy after sector resection for ductal carcinoma in situ of the breast. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  I. Ellis,et al.  Accuracy of mammography in predicting histological extent of ductal carcinoma in situ (DCIS). , 2006, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[7]  K. Mokbel,et al.  Heterogeneity of ductal carcinoma in situ and its effects on management. , 2006, The Lancet. Oncology.

[8]  J. Peterse,et al.  Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853--a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  V. Tsikitis,et al.  Biology of Ductal Carcinoma in Situ Classification Based on Biologic Potential , 2006, American journal of clinical oncology.

[10]  J. Peterse,et al.  Breast-conserving treatment with or without radiotherapy for ductal carcinoma in situ (DCIS): ten-year results of European Organisation for Research and Treatment of Cancer (EORTC) randomized phase III trial 10853 , 2006 .

[11]  L. Holmberg,et al.  SweDCIS: Radiotherapy after sector resection for ductal carcinoma in situ of the breast. Results of a randomised trial in a population offered mammography screening , 2006, Acta oncologica.

[12]  R. Collins,et al.  Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials , 2005, The Lancet.

[13]  L. Tabár,et al.  Overdiagnosis and overtreatment of breast cancer: Estimates of overdiagnosis from two trials of mammographic screening for breast cancer , 2005, Breast Cancer Research.

[14]  J. Cuzick.  Treatment of DCIS--results from clinical trials. , 2003, Surgical oncology.

[15]  J. Houghton.  Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomized controlled trial , 2003, The Lancet.

[16]  I. Ellis,et al.  Screen detected ductal carcinoma in situ (DCIS): overdiagnosis or an obligate precursor of invasive disease? , 2001, Journal of medical screening.

[17]  N. Wolmark,et al.  Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the National Surgical Adjuvant Breast and Bowel Project experience. , 2001, Seminars in oncology.

[18]  James Dignam,et al.  Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial , 1999, The Lancet.

[19]  J. Costantino,et al.  Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  B Fisher,et al.  Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer. , 1993, The New England journal of medicine.

[21]  T. Gibson,et al.  INFECTION IN INFANCY. , 1965, Lancet.

[22]  N. Bijker,et al.  Breast-conserving therapy for ductal carcinoma in situ Bijker , 2008 .

[23]  J. Cuzick.  Aromatase inhibitors in prevention--data from the ATAC (arimidex, tamoxifen alone or in combination) trial and the design of IBIS-II (the second International Breast Cancer Intervention Study). , 2003, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[24]  Jack Cuzick,et al.  Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. An overview of 61 randomized trials among 28,896 women , 1988 .